SCCMS Enhanced Equity Income Fund Sold Baxter Int’l (BAX) Due to Near-Term Headwinds

2 weeks ago 9

Soumya Eswaran

Fri, December 5, 2025 astatine 8:07 AM CST 3 min read

Cullen Capital Management, LLC, operating nether the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Enhanced Equity Income Fund” third-quarter capitalist letter. A transcript of the missive tin beryllium downloaded here. US equities continued to emergence successful the 3rd quarter, with the S&P 500 returning 8.1% portion the Russell 1000 Value was up 5.3%. The composite returned 0.9% (net) successful the quarter, compared to a 3.5% instrumentality for the S&P 500 Buy-Write Index (BXM) and a 2.5% instrumentality for the SPDR Bloomberg High Yield Bond ETF (JNK). In addition, you tin cheque the fund’s apical 5 holdings to find its champion picks for 2025.

In its third-quarter 2025 capitalist letter, SCCM Enhanced Equity Income Fund highlighted stocks specified arsenic Baxter International Inc. (NYSE:BAX). Baxter International Inc. (NYSE:BAX) is simply a healthcare institution that offers a portfolio of healthcare products. The one-month instrumentality for Baxter International Inc. (NYSE:BAX) was 2.67%, and its shares gained 41.89% implicit the past 52 weeks. On December 04, 2025, Baxter International Inc. (NYSE:BAX) banal closed astatine $18.48 per share, with a marketplace capitalization of $9.5 billion.

SCCM Enhanced Equity Income Fund stated the pursuing regarding Baxter International Inc. (NYSE:BAX) successful its 3rd 4th 2025 capitalist letter:

"Our presumption successful Baxter International Inc. (NYSE:BAX) was sold successful the quarter. While Baxter has historically provided beardown returns to shareholders, its shares person importantly lagged since the onset of the Covid pandemic successful 2020. Although absorption had a program to retrieve from Covid epoch challenges and amended its profitability, including the merchantability of its underperforming Kidney Care concern to backstage equity, borderline unit continued successful 2024. Management chopped the dividend by 40% successful aboriginal 2025 to amended its fiscal spot and announced a CEO alteration successful July. However, Baxter faced ongoing pricing unit from infirmary Group Purchasing Organizations (GPOs) successful 2025, and faced operational challenges including information incidents with its Novum IQ ample measurement pump that forced absorption to chopped the afloat twelvemonth net outlook. Although Baxter inactive has betterment imaginable successful implicit the long-term, we decided to exit the presumption fixed the aggregate near-term headwinds."

Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts?

Baxter International Inc. (NYSE:BAX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 38 hedge money portfolios held Baxter International Inc. (NYSE:BAX) astatine the extremity of the 3rd quarter, up from 31 successful the erstwhile quarter. While we admit the imaginable of Baxter International Inc. (NYSE:BAX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.